Intellectual Property UK

  • April 23, 2024

    Novartis Wins TM Fight After Trade Services Linked To Retail

    Altamedics has lost a bid to register a trademark for its name after European officials ruled that buyers would think its products came from Novartis, which had already registered the "Alta" brand for similar pharmaceutical goods.

  • April 23, 2024

    Panasonic Accused Of 'Illegitimate Pressure' In Patent Fight

    Chinese electronics giant Xiaomi asked a London court on Tuesday to prevent Panasonic from suing it in overseas jurisdictions amid a patent dispute, arguing that its Japanese rival is using the threat of injunctions to put pressure on it to accept a licensing deal.

  • April 23, 2024

    Pfizer Says Moderna MRNA Patent Offers Nothing New

    Pfizer urged a London court on Tuesday to revoke one of Moderna's patents for the mRNA vaccine, kicking off the U.K. arm of the global litigation campaign over the central intellectual property behind the COVID-19 jabs.

  • April 22, 2024

    Pfizer, Moderna Set To Tee Off Over COVID-19 Vaccine Patents

    A London court is poised to consider Tuesday whether Pfizer infringed patents that Moderna initially pledged to not enforce, marking the first time a court has weighed in on the topic.

  • April 22, 2024

    Abbott Says Rival Can Make Diabetes Tech Without TM Shape

    An Abbott Laboratories unit is defending a 3D trademark it owns over its continuous glucose monitoring devices, arguing that it is the only company offering a device in that distinctive circular shape despite Sinocare Inc. and other rivals' arguments to the contrary.

  • April 22, 2024

    EUIPO Sets Out New Policies For TMs With Morality Woes

    The European Union Intellectual Property Office said Friday it has begun the three-month roll-out for new rules governing morality principles in trademark registration, marking the first time the EU has taken a harmonized approach to the subject.

  • April 22, 2024

    Sandoz Gets Jazz's Cancer Treatment Patent Nixed

    Jazz Pharmaceuticals has lost a patent for fat-based drug preparations to treat cancer after European officials ruled that it wasn't innovative.

  • April 22, 2024

    HR Software Giant Can Fight On To Register 'Standout' TM

    American software giant ADP will have a second chance to attempt to register the word "standout" as a trademark in the European Union, even though the bloc's intellectual property authority decided that the mark failed to meet basic trademark requirements.

  • April 22, 2024

    Kirkland-Led Blackstone Bids $1.2B For Music Biz Hipgnosis

    Private equity firm Blackstone has tabled an enhanced $1.2 billion bid for U.K. music royalties investment company Hipgnosis, countering an offer from U.S. royalties firm Concord Chorus.

  • April 19, 2024

    Royal Mail Accuses Developer Of Copying Postcode Database

    Royal Mail has accused a software developer of using its database of postcode information to set up its own address-finding company.

  • April 19, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen U.K. holiday resort chain Butlins target Aviva and a huddle of insurers, Meta and WhatsApp tackle a patents claim by telecommunications company Semitel, an ongoing construction dispute between Essex County Council and Balfour Beatty, and Formycon AG hit a pharmaceutical company for infringing medical products. Here, Law360 looks at these and other new claims in the U.K.

  • April 19, 2024

    UKIPO Halts Takeoff For Admin-Based Aircraft Docking Patent

    An engineering company cannot protect its aircraft docking invention with a U.K. patent because it is an administrative activity which is outside the realms of patentability, the nation's Intellectual Property Office has ruled.

  • April 19, 2024

    'Oktoberfest' Too Descriptive For Munich To Get TM

    The city of Munich has failed to revive its "Oktoberfest" trademark protections over beer glasses and clothing after a European Union appeals panel ruled that the sign is too descriptive of the festival-inspired style of the goods.

  • April 19, 2024

    5 Questions For Taylor Wessing's Roland Mallinson

    Roland Mallinson had dreamed as a child of becoming an architect, but a teacher set him on a different course, steering him toward the path of civil engineering before he eventually became an intellectual property lawyer.

  • April 18, 2024

    Patent Court Edges Closer To Transparency With Ocado Decision

    The Unified Patent Court gave an early signal this month about its willingness to make proceedings transparent by agreeing to let an outside lawyer see pleadings in a high-profile case, but some lawyers warned that the court had not gone far enough to guarantee openness at the new court.

  • April 18, 2024

    Ericsson Can't Push Lenovo's FRAND Claim Out Of UK

    Swedish telecom Ericsson has failed to force Lenovo's claim over patent licensing terms out of the U.K., as a London judge on Thursday concluded that the English courts are "clearly the most appropriate" forum for the Chinese multinational's case.

  • April 18, 2024

    Dexcom Asks EU Court To Toss Abbott Med Tech Patent

    Medical device maker Dexcom Inc. has asked Europe's patent court to revoke Abbott Diabetes Care Inc.'s patent for glucose monitor screens, firing back at its rival in a sprawling international battle over the technology.

  • April 18, 2024

    Truffle Specialist Can't Protect 'Cipriani Tartufi' TM In EU

    An Italian truffle distributor cannot register his "Cipriani Tartufi" trademark in the European Union because it is too similar to a luxury food specialist's "Cipriani Food" branding, an intellectual property appeals panel in the bloc has ruled.

  • April 25, 2024

    Mathys & Squire Recruits New IP Partner To Munich Office

    Mathys & Squire LLP has hired a new intellectual property partner in its Munich office from Müller Hoffmann & Partner in its latest move toward delivering all-German advice to clients in the nation.

  • April 17, 2024

    Escobar TM Too Shocking For General Public, EU Court Rules

    A European court refused Wednesday to let cocaine kingpin Pablo Escobar's family trademark his name because of its "highly offensive and shocking" associations with drug trafficking and narcoterrorism.

  • April 17, 2024

    Coinbase Loses EU Appeal To Bloc Rival TM

    Coinbase lost part of its bid Wednesday to stop an Estonian company bearing the same name from registering a trademark, with a European court saying the cryptocurrency platform cannot block the trademark of the Baltic state business for news services, publishing or education.

  • April 17, 2024

    Ireland Pushes Back UPC Ratification Vote

    The Irish government has pushed back the date for a referendum to decide whether it should ratify the agreement to join Europe's Unified Patent Court, citing the need for more public engagement on the matter.

  • April 17, 2024

    Chinese Vape Maker Accuses UK Co. Of Bumming Designs

    A Chinese vape maker has accused a rival of selling products that look identical to its SKE Crystal Bar, infringing its intellectual property by using the "Crystal" name and misrepresenting their vapes to British consumers.

  • April 17, 2024

    Intel Urges Court To Revoke Semiconductor's Chip Patent

    Computer processor giant Intel denied infringing the intellectual property of R2, telling a judge Wednesday that the chip patent that the semiconductor maker is trying to enforce is invalid because it represents developments already known in the industry.

  • April 17, 2024

    Toto's Toilet Patent Flushed Over Obviousness

    A Japanese toilet maker failed to secure a patent for a cleaning device placed above toilet seats, after European officials ruled that a skilled person would have eventually combined previous inventions to make its key features.

Expert Analysis

  • Examining EPO's Strict Approach To AI Patent Disclosure

    Author Photo

    Because a recent decision by the European Patent Office Boards of Appeal takes a potentially problematic strict approach to disclosure requirements for machine learning-related patent applications, U.S. applicants filing in the EU should disclose several specific data training sets, says Ronny Amirsehhi at Clifford Chance.

  • ITC Dispute May Lead To PTAB Litigation Strategy Shifts

    Author Photo

    A pending motion to stay the dispute between AutoStore and Ocado at the U.S. International Trade Commission highlights competing timelines of the ITC and Patent Trial and Appeal Board, and has the potential to reshape the typical forum selection strategies for patentees and defense tactics for challengers, say attorneys at Reichman Jorgensen.

  • Opinion

    US Courts Should Adjudicate FRAND Rates On A Global Basis

    Author Photo

    Following the U.K. Supreme Court's recent Unwired Planet v. Huawei decision, U.S. courts should analyze compliance with contracts on fair, reasonable and nondiscriminatory terms by assessing them on a worldwide basis, because global licenses are the only technically and financially sound way to license standard-essential patents, say attorneys at McKool Smith.

  • UK Top Court Ruling May Be Problematic For Global SEP Suits

    Author Photo

    There are several reasons to question the wisdom of the U.K. Supreme Court's recent ruling that English judges have the power to set extraterritorial licensing royalty rates for standard-essential patents, including that it encourages forum shopping, says Thomas Cotter at the University of Minnesota Law School.

  • UK Ruling Shows Global SEP Enforcement Dilemma

    Author Photo

    The U.K. Supreme Court's recent ruling that U.K. judges have the power to set extraterritorial licensing royalty rates for standard-essential patents highlights a problem with global patent enforcement coordination and efficiency that could potentially be solved through the Patent Cooperation Treaty, says Roya Ghafele at Oxfirst.

  • Time To Reassess Your Patent Cooperation Treaty Strategy

    Author Photo

    In light of the trends outlined in the World Intellectual Property Organization's recent annual Patent Cooperation Treaty review, applicants should make decisions on which international search authority to use based on immediate cost, total cost and quality, says Karam Saab at Kilpatrick.

  • German FRAND Decision May Shape Global SEP Landscape

    Author Photo

    The German high court's recent decision that patent owner Sisvel didn't breach its fair, reasonable and nondiscriminatory patent licensing obligations by refusing to grant Haier a license represents a shift in the standard-essential patent landscape in favor of SEP holders' enforcement freedom, say Erik Puknys and Michelle Rice at Finnegan.

  • Sustainable Food Progress May Close Global Regulatory Gap

    Author Photo

    As the need for sustainable food production grows, the European sector will likely align with less stringent U.S. regulatory standards, which will further enable U.S. companies to expand globally and lead to more sophisticated intellectual property strategies in all regions, say Jane Hollywood and Fiona Carter at CMS Legal.

  • Cos. Should Assess IP, Contractual Protections For Their AI

    Author Photo

    Companies should understand the three types of intellectual property protection for safeguarding proprietary artificial intelligence — which is crucial to fighting the pandemic — as well as tools for creating protections when statutory means fall short, say Lori Bennett at Aetion and attorneys at Mayer Brown.

  • Tips For Accelerating Patent Prosecution In China

    Author Photo

    In light of recent Chinese patent statistics showing at least eight to 10 months to first office action and an average of 22.7 months to final disposition from the date of filing, there are several strategies applicants may explore to speed through examination, say Aaron Wininger at Schwegman Lundberg and Lei Tan at Pujing Chemical.

  • Use Of AI To Treat COVID-19 Shows Novel Inventorship Issues

    Author Photo

    As technology and medical companies collaborate to deploy artificial intelligence to combat COVID-19, questions arise about how best to protect AI innovations as well as who should get credit as an inventor, say attorneys at Cadwalader.

  • Israel's Generic COVID-19 Drug Licensing Lacks Due Process

    Author Photo

    The Israel attorney general's special compulsory license for imported generic versions of Abbvie's patented antiviral drug Kaletra to treat COVID-19 does not provide a right of response, a hearing or direct judicial review, says Ephraim Heiliczer at Pearl Cohen.

  • New US Policy On SEP Remedies Restores Critical Balance

    Author Photo

    The new joint U.S. Department of Justice-U.S. Patent and Trademark Office policy on standard-essential patents, clarifying that injunctions are available in accordance with general remedies law, helps restore a power balance between technology innovators and users, and realigns U.S. patent law with other jurisdictions, say attorneys at McKool Smith.

  • Vaccine IP Under Microscope With Coronavirus Outbreak

    Author Photo

    The coronavirus global outbreak, which has focused attention on the role patent systems play in encouraging investment in vaccines and cures, affords an opportunity to examine the tension among patent rights, investments, governments and public health, say Gaby Longsworth and Robert Greene Sterne at Sterne Kessler.

  • EU Lacks Effective Tool For Resolving Border Disputes

    Author Photo

    The European Court of Justice recently found that it did not have jurisdiction over Slovenia's claim to enforce an arbitration award against Croatia, indicating that EU legal framework cannot be used to resolve intra-EU border disputes, and that a new mechanism should possibly be developed, says Akshay Sewlikar at Linklaters.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!